The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Finasteride Tablets-Global Market Insights and Sales Trends 2025
Synopsis
Finasteride, sold under the brand names Proscar and Propecia among others, is a medication used for the treatment of benign prostatic hyperplasia (BPH) and male pattern baldness (MPB).
The global Finasteride Tablets market size is expected to reach US$ 155.9 million by 2029, growing at a CAGR of 3.9% from 2023 to 2029. The market is mainly driven by the significant applications of Finasteride Tablets in various end use industries. The expanding demands from the Benign Prostatic Hyperplasia, Male Pattern Baldness and Others,, are propelling Finasteride Tablets market. 1mg Tablet, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the 5mg Tablet segment is estimated at % CAGR for the next seven-year period.
Asia Pacific shows high growth potential for Finasteride Tablets market, driven by demand from China, the second largest economy with some signs of stabilising, the Finasteride Tablets market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Finasteride Tablets, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Finasteride Tablets market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Finasteride Tablets market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Finasteride Tablets sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Finasteride Tablets covered in this report include Merck, Actavis, Sandoz, Teva Pharmaceuticals, Cipla, RelonChem, Dr. Reddy, Accord Pharmaceuticals and Henan Topfond, etc.
The global Finasteride Tablets market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Merck
Actavis
Sandoz
Teva Pharmaceuticals
Cipla
RelonChem
Dr. Reddy
Accord Pharmaceuticals
Henan Topfond
Zhejiang CONBA Pharmaceutical
Shandong Renhetang Pharmaceutical
Guangdong Eashu Pharmacetical
Global Finasteride Tablets market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Finasteride Tablets market, Segment by Type:
1mg Tablet
5mg Tablet
Global Finasteride Tablets market, by Application
Benign Prostatic Hyperplasia
Male Pattern Baldness
Others
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Finasteride Tablets manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Finasteride Tablets in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Finasteride, sold under the brand names Proscar and Propecia among others, is a medication used for the treatment of benign prostatic hyperplasia (BPH) and male pattern baldness (MPB).
The global Finasteride Tablets market size is expected to reach US$ 155.9 million by 2029, growing at a CAGR of 3.9% from 2023 to 2029. The market is mainly driven by the significant applications of Finasteride Tablets in various end use industries. The expanding demands from the Benign Prostatic Hyperplasia, Male Pattern Baldness and Others,, are propelling Finasteride Tablets market. 1mg Tablet, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the 5mg Tablet segment is estimated at % CAGR for the next seven-year period.
Asia Pacific shows high growth potential for Finasteride Tablets market, driven by demand from China, the second largest economy with some signs of stabilising, the Finasteride Tablets market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Finasteride Tablets, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Finasteride Tablets market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Finasteride Tablets market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Finasteride Tablets sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Finasteride Tablets covered in this report include Merck, Actavis, Sandoz, Teva Pharmaceuticals, Cipla, RelonChem, Dr. Reddy, Accord Pharmaceuticals and Henan Topfond, etc.
The global Finasteride Tablets market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Merck
Actavis
Sandoz
Teva Pharmaceuticals
Cipla
RelonChem
Dr. Reddy
Accord Pharmaceuticals
Henan Topfond
Zhejiang CONBA Pharmaceutical
Shandong Renhetang Pharmaceutical
Guangdong Eashu Pharmacetical
Global Finasteride Tablets market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Finasteride Tablets market, Segment by Type:
1mg Tablet
5mg Tablet
Global Finasteride Tablets market, by Application
Benign Prostatic Hyperplasia
Male Pattern Baldness
Others
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Finasteride Tablets manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Finasteride Tablets in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index1 Finasteride Tablets Market Overview
1.1 Finasteride Tablets Product Overview
1.2 Finasteride Tablets Market Segment by Type
1.2.1 1mg Tablet
1.2.2 5mg Tablet
1.3 Global Finasteride Tablets Market Size by Type
1.3.1 Global Finasteride Tablets Market Size Overview by Type (2018-2029)
1.3.2 Global Finasteride Tablets Historic Market Size Review by Type (2018-2023)
1.3.3 Global Finasteride Tablets Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Finasteride Tablets Sales Breakdown by Type (2018-2023)
1.4.2 Europe Finasteride Tablets Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Finasteride Tablets Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Finasteride Tablets Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Finasteride Tablets Sales Breakdown by Type (2018-2023)
2 Global Finasteride Tablets Market Competition by Company
2.1 Global Top Players by Finasteride Tablets Sales (2018-2023)
2.2 Global Top Players by Finasteride Tablets Revenue (2018-2023)
2.3 Global Top Players by Finasteride Tablets Price (2018-2023)
2.4 Global Top Manufacturers Finasteride Tablets Manufacturing Base Distribution, Sales Area, Product Type
2.5 Finasteride Tablets Market Competitive Situation and Trends
2.5.1 Finasteride Tablets Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Finasteride Tablets Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Finasteride Tablets as of 2022)
2.7 Date of Key Manufacturers Enter into Finasteride Tablets Market
2.8 Key Manufacturers Finasteride Tablets Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Finasteride Tablets Status and Outlook by Region
3.1 Global Finasteride Tablets Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Finasteride Tablets Historic Market Size by Region
3.2.1 Global Finasteride Tablets Sales in Volume by Region (2018-2023)
3.2.2 Global Finasteride Tablets Sales in Value by Region (2018-2023)
3.2.3 Global Finasteride Tablets Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Finasteride Tablets Forecasted Market Size by Region
3.3.1 Global Finasteride Tablets Sales in Volume by Region (2024-2029)
3.3.2 Global Finasteride Tablets Sales in Value by Region (2024-2029)
3.3.3 Global Finasteride Tablets Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Finasteride Tablets by Application
4.1 Finasteride Tablets Market Segment by Application
4.1.1 Benign Prostatic Hyperplasia
4.1.2 Male Pattern Baldness
4.1.3 Others
4.2 Global Finasteride Tablets Market Size by Application
4.2.1 Global Finasteride Tablets Market Size Overview by Application (2018-2029)
4.2.2 Global Finasteride Tablets Historic Market Size Review by Application (2018-2023)
4.2.3 Global Finasteride Tablets Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Finasteride Tablets Sales Breakdown by Application (2018-2023)
4.3.2 Europe Finasteride Tablets Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Finasteride Tablets Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Finasteride Tablets Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Finasteride Tablets Sales Breakdown by Application (2018-2023)
5 North America Finasteride Tablets by Country
5.1 North America Finasteride Tablets Historic Market Size by Country
5.1.1 North America Finasteride Tablets Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Finasteride Tablets Sales in Volume by Country (2018-2023)
5.1.3 North America Finasteride Tablets Sales in Value by Country (2018-2023)
5.2 North America Finasteride Tablets Forecasted Market Size by Country
5.2.1 North America Finasteride Tablets Sales in Volume by Country (2024-2029)
5.2.2 North America Finasteride Tablets Sales in Value by Country (2024-2029)
6 Europe Finasteride Tablets by Country
6.1 Europe Finasteride Tablets Historic Market Size by Country
6.1.1 Europe Finasteride Tablets Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Finasteride Tablets Sales in Volume by Country (2018-2023)
6.1.3 Europe Finasteride Tablets Sales in Value by Country (2018-2023)
6.2 Europe Finasteride Tablets Forecasted Market Size by Country
6.2.1 Europe Finasteride Tablets Sales in Volume by Country (2024-2029)
6.2.2 Europe Finasteride Tablets Sales in Value by Country (2024-2029)
7 Asia-Pacific Finasteride Tablets by Region
7.1 Asia-Pacific Finasteride Tablets Historic Market Size by Region
7.1.1 Asia-Pacific Finasteride Tablets Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Finasteride Tablets Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Finasteride Tablets Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Finasteride Tablets Forecasted Market Size by Region
7.2.1 Asia-Pacific Finasteride Tablets Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Finasteride Tablets Sales in Value by Region (2024-2029)
8 Latin America Finasteride Tablets by Country
8.1 Latin America Finasteride Tablets Historic Market Size by Country
8.1.1 Latin America Finasteride Tablets Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Finasteride Tablets Sales in Volume by Country (2018-2023)
8.1.3 Latin America Finasteride Tablets Sales in Value by Country (2018-2023)
8.2 Latin America Finasteride Tablets Forecasted Market Size by Country
8.2.1 Latin America Finasteride Tablets Sales in Volume by Country (2024-2029)
8.2.2 Latin America Finasteride Tablets Sales in Value by Country (2024-2029)
9 Middle East and Africa Finasteride Tablets by Country
9.1 Middle East and Africa Finasteride Tablets Historic Market Size by Country
9.1.1 Middle East and Africa Finasteride Tablets Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Finasteride Tablets Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Finasteride Tablets Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Finasteride Tablets Forecasted Market Size by Country
9.2.1 Middle East and Africa Finasteride Tablets Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Finasteride Tablets Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Merck
10.1.1 Merck Company Information
10.1.2 Merck Introduction and Business Overview
10.1.3 Merck Finasteride Tablets Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Merck Finasteride Tablets Products Offered
10.1.5 Merck Recent Development
10.2 Actavis
10.2.1 Actavis Company Information
10.2.2 Actavis Introduction and Business Overview
10.2.3 Actavis Finasteride Tablets Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Actavis Finasteride Tablets Products Offered
10.2.5 Actavis Recent Development
10.3 Sandoz
10.3.1 Sandoz Company Information
10.3.2 Sandoz Introduction and Business Overview
10.3.3 Sandoz Finasteride Tablets Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Sandoz Finasteride Tablets Products Offered
10.3.5 Sandoz Recent Development
10.4 Teva Pharmaceuticals
10.4.1 Teva Pharmaceuticals Company Information
10.4.2 Teva Pharmaceuticals Introduction and Business Overview
10.4.3 Teva Pharmaceuticals Finasteride Tablets Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Teva Pharmaceuticals Finasteride Tablets Products Offered
10.4.5 Teva Pharmaceuticals Recent Development
10.5 Cipla
10.5.1 Cipla Company Information
10.5.2 Cipla Introduction and Business Overview
10.5.3 Cipla Finasteride Tablets Sales, Revenue and Gross Margin (2018-2023)
10.5.4 Cipla Finasteride Tablets Products Offered
10.5.5 Cipla Recent Development
10.6 RelonChem
10.6.1 RelonChem Company Information
10.6.2 RelonChem Introduction and Business Overview
10.6.3 RelonChem Finasteride Tablets Sales, Revenue and Gross Margin (2018-2023)
10.6.4 RelonChem Finasteride Tablets Products Offered
10.6.5 RelonChem Recent Development
10.7 Dr. Reddy
10.7.1 Dr. Reddy Company Information
10.7.2 Dr. Reddy Introduction and Business Overview
10.7.3 Dr. Reddy Finasteride Tablets Sales, Revenue and Gross Margin (2018-2023)
10.7.4 Dr. Reddy Finasteride Tablets Products Offered
10.7.5 Dr. Reddy Recent Development
10.8 Accord Pharmaceuticals
10.8.1 Accord Pharmaceuticals Company Information
10.8.2 Accord Pharmaceuticals Introduction and Business Overview
10.8.3 Accord Pharmaceuticals Finasteride Tablets Sales, Revenue and Gross Margin (2018-2023)
10.8.4 Accord Pharmaceuticals Finasteride Tablets Products Offered
10.8.5 Accord Pharmaceuticals Recent Development
10.9 Henan Topfond
10.9.1 Henan Topfond Company Information
10.9.2 Henan Topfond Introduction and Business Overview
10.9.3 Henan Topfond Finasteride Tablets Sales, Revenue and Gross Margin (2018-2023)
10.9.4 Henan Topfond Finasteride Tablets Products Offered
10.9.5 Henan Topfond Recent Development
10.10 Zhejiang CONBA Pharmaceutical
10.10.1 Zhejiang CONBA Pharmaceutical Company Information
10.10.2 Zhejiang CONBA Pharmaceutical Introduction and Business Overview
10.10.3 Zhejiang CONBA Pharmaceutical Finasteride Tablets Sales, Revenue and Gross Margin (2018-2023)
10.10.4 Zhejiang CONBA Pharmaceutical Finasteride Tablets Products Offered
10.10.5 Zhejiang CONBA Pharmaceutical Recent Development
10.11 Shandong Renhetang Pharmaceutical
10.11.1 Shandong Renhetang Pharmaceutical Company Information
10.11.2 Shandong Renhetang Pharmaceutical Introduction and Business Overview
10.11.3 Shandong Renhetang Pharmaceutical Finasteride Tablets Sales, Revenue and Gross Margin (2018-2023)
10.11.4 Shandong Renhetang Pharmaceutical Finasteride Tablets Products Offered
10.11.5 Shandong Renhetang Pharmaceutical Recent Development
10.12 Guangdong Eashu Pharmacetical
10.12.1 Guangdong Eashu Pharmacetical Company Information
10.12.2 Guangdong Eashu Pharmacetical Introduction and Business Overview
10.12.3 Guangdong Eashu Pharmacetical Finasteride Tablets Sales, Revenue and Gross Margin (2018-2023)
10.12.4 Guangdong Eashu Pharmacetical Finasteride Tablets Products Offered
10.12.5 Guangdong Eashu Pharmacetical Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Finasteride Tablets Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Finasteride Tablets Industrial Chain Analysis
11.4 Finasteride Tablets Market Dynamics
11.4.1 Finasteride Tablets Industry Trends
11.4.2 Finasteride Tablets Market Drivers
11.4.3 Finasteride Tablets Market Challenges
11.4.4 Finasteride Tablets Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Finasteride Tablets Distributors
12.3 Finasteride Tablets Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
